Optimisation of insulin treatment of type 2 diabetes mellitus by Telecare assistance for self monitoring of blood glucose (SMBG).
Phase of Trial: Phase III
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ELEONOR
- Sponsors Sanofi
- 07 Jun 2017 Biomarkers information updated
- 05 Jun 2009 Quality-of-life and treatment satisfaction results presented at ADA 2009.
- 12 May 2009 Actual patient number (352) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History